COSMOS Pharmaceutical Cash Flow Statement

Financials in millions JPY. Fiscal year is June - May.

Millions JPY. Fiscal year is Jun - May.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '25 Nov 30, 2025	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022	May '21 May 31, 2021
Net Income	42,592	42,372	33,719	32,773	33,048	38,596
Depreciation & Amortization	23,362	22,229	19,924	17,368	15,110	13,785
Loss (Gain) From Sale of Assets	387	508	937	113	-195	-4,159
Other Operating Activities	-12,073	-9,586	-8,646	-9,034	-13,188	-9,090
Change in Accounts Receivable	-126	-123	-185	-254	-97	8
Change in Inventory	-5,944	-6,182	-8,704	-11,156	-5,853	-7,006
Change in Accounts Payable	12,418	-2,423	17,697	22,627	6,183	-3,491
Change in Other Net Operating Assets	-1,087	5,672	433	1,997	-2,814	-768
Operating Cash Flow	59,529	52,467	55,175	54,434	32,194	27,875
Operating Cash Flow Growth	11.66%	-4.91%	1.36%	69.08%	15.49%	-57.42%
Capital Expenditures	-59,991	-53,326	-55,810	-46,636	-43,497	-26,064
Sale of Property, Plant & Equipment	291	-	718	46	1,519	8,677
Other Investing Activities	-2,204	-2,122	-2,237	-2,523	-1,739	-1,994
Investing Cash Flow	-61,904	-55,448	-57,329	-49,113	-43,717	-19,381
Long-Term Debt Issued	-	20,000	18,400	10,000	300	-
Long-Term Debt Repaid	-	-5,082	-3,193	-1,628	-1,486	-1,486
Net Debt Issued (Repaid)	14,426	14,918	15,207	8,372	-1,186	-1,486
Repurchase of Common Stock	-1	-2	-	-	-2	-
Common Dividends Paid	-5,550	-4,959	-4,659	-3,266	-3,266	-2,277
Other Financing Activities	-2,389	-2,240	-2,021	-1,861	-1,768	-1,744
Financing Cash Flow	6,486	7,717	8,527	3,245	-6,222	-5,507
Miscellaneous Cash Flow Adjustments	-	-	-	-	-	-2
Net Cash Flow	4,111	4,736	6,373	8,566	-17,745	2,985
Free Cash Flow	-462	-859	-635	7,798	-11,303	1,811
Free Cash Flow Growth	-	-	-	-	-	-95.42%
Free Cash Flow Margin	-0.04%	-0.08%	-0.07%	0.94%	-1.50%	0.25%
Free Cash Flow Per Share	-5.83	-10.84	-8.01	98.46	-142.72	22.87
Cash Interest Paid	379	258	101	51	52	60
Cash Income Tax Paid	11,841	9,571	8,993	9,111	13,337	9,103
Levered Free Cash Flow	-5,994	-6,530	-7,985	5,044	-15,323	-2,005
Unlevered Free Cash Flow	-5,760	-6,372	-7,923	5,076	-15,291	-1,967
Change in Working Capital	5,261	-3,056	9,241	13,214	-2,581	-11,257

Source: S&P Global Market Intelligence. Standard template. Financial Sources.